Biofrontera Short Interest Ratio and Short Volume

Biofrontera (NASDAQ:BFRA) Short Interest Frequently Asked Questions

What is Biofrontera's current short interest?

Short interest is the volume of Biofrontera shares that have been sold short but have not yet been closed out or covered. As of November 15th, investors have sold 2,600 shares of BFRA short. Learn More on Biofrontera's current short interest.

Is Biofrontera's short interest increasing or decreasing?

Biofrontera saw a increase in short interest in November. As of November 15th, there was short interest totaling 2,600 shares, an increase of 2,500.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Biofrontera's short interest compare to its competitors?

0.00% of Biofrontera's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Biofrontera: Aldeyra Therapeutics, Inc (6.11%), Provention Bio, Inc. (4.56%), CytomX Therapeutics, Inc. (7.48%), Vaccitech plc (0.00%), Greenwich LifeSciences, Inc. (3.11%), Pharvaris (0.33%), BELLUS Health Inc. (5.99%), Arbutus Biopharma Co. (0.00%), Rallybio Corp (2.94%), and Viking Therapeutics, Inc. (6.80%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($11.06 billion), S&P Global Inc. ($8.74 billion), Charter Communications, Inc. ($5.66 billion), Canadian Pacific Railway Limited ($5.43 billion), Wayfair Inc. ($4.23 billion), Palo Alto Networks, Inc. ($3.46 billion), DoorDash, Inc. ($3.41 billion), Teladoc Health, Inc. ($2.84 billion), Etsy, Inc. ($2.76 billion), and Zscaler, Inc. ($2.62 billion). View all of the most shorted stocks.

What does it mean to sell short Biofrontera stock?

Short selling BFRA is an investing strategy that aims to generate trading profit from Biofrontera as its price is falling. Biofrontera's stock is trading down $0.22 today. To short Biofrontera stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Biofrontera will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Biofrontera?

A short squeeze for Biofrontera occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BFRA, which in turn drives the price of the stock up even further.

How often is Biofrontera's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BFRA, twice per month. The most recent reporting period available is November, 15 2021.